|Articles|July 1, 2002
Eye drops delay onset of glaucoma
Author(s)Lynda Charters
Bethesda, MD-Glaucoma management has entered a new era. Based on the results of the long-awaited Ocular Hypertension Treatment Study (OHTS), physicians now have clear guidelines for treating patients at high risk for developing glaucoma that may actually prevent the disease.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
2
Long-lived Greenland sharks may point to new approaches for retinal disease
3
Orbital and retinal microvascular changes in thyroid eye disease
4
STAAR Surgical terminates proposed acquisition by Alcon
5








































